Naples Community Hospital and NeoGenomics Team up to Serve South Florida Cancer Patients.

Business Editors/Health & Medical Writers

NAPLES, Fla.--(BUSINESS WIRE)--Sept. 4, 2002

NeoGenomics (OTCBB:NOGN) announced today that Naples Community Hospital (NCH) is the latest addition to their client roster, marking the Company's first hospital customer.

NeoGenomics first approached the premiere hospital in Naples, Florida to provide high-end genetic testing services shortly after receiving certification of the Company's clinical laboratory. Upon successfully completing multiple trial tests spanning several weeks, the "Genostics" laboratory is now providing a significant amount of cancer cytogenetics testing for the pathology department of the Naples Community Hospital. Company President, Dr. Michael Dent stated, "The increase in testing for NCH is largely due to our outstanding performance during the trial test periods, and we are noticing the same enthusiasm and interest from other hospitals in the Southwest Florida area. We will work on developing these important hospital relationships as NeoGenomics continues to grow."

Known for its pioneering cancer treatments and therapies, NCH's Regional Cancer Center is highly respected for their superior hematological and gynecological oncology services. Aside from NCH's patients seen on an in/out-patient basis, the hospital serves an extensive network of oncologists in the surrounding Lee and Collier Counties. Dr. David Greider, Pathologist at NCH, says, "Accurate and timely diagnoses is crucial for cancer patients. NeoGenomics' response time has consistently surpassed competitor labs, in some instances reducing test result times by 66%, allowing physicians to discuss treatment options with their patients as early as possible."

NeoGenomics has a comprehensive cancer cytogenetics test menu. The majority of testing requested by the NCH's pathology department is on bone marrow and peripheral blood samples for the diagnosis and therapeutic monitoring of various leukemias and other hematopoietic disorders. All tests requested may include genetic counseling for patients from the Company's board-certified clinical cytogeneticists.

About Naples Community Hospital

The Naples Community Hospital is a 408-bed facility serving the medical needs of the Southwest Florida counties. NCH has more than 500 physicians, whose specialties include cardiology, oncology; inpatient and outpatient rehabilitation; psychiatry, pediatric emergency medicine; surgery, diagnostics, and more. For more information, please visit their site at: http://www.nchmd.org/NaplesCommunityHospital/nch.htm.

About NeoGenomics, Inc.

NeoGenomics, Inc. has established a state-of-the-art genetic/diagnostic or "Genostics" laboratory. The Company's principle goal is to conduct research and develop products for the early diagnosis of women's diseases, such as ovarian cancer, as well as diseases in prenatal infants. At the same time, the Company is utilizing its laboratory facilities to perform diagnostic procedures for outside clients, which is expected to provide the Company with an ongoing source of working capital to support its research division. For additional information on NeoGenomics, go to: http://www.neogenomics.org.

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to establish its laboratory, develop useful applications from its planned research and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.